期刊文献+

辐照灭菌在同种骨移植物制备中的应用 被引量:3

Application of Radiation Sterilizationn to Bone Allografts
下载PDF
导出
摘要 辐照灭菌具有穿透力强、无明显温度升高、无有害物质残留和剂量容易控制等优点 ,被广泛用于同种骨移植物的灭菌。辐照灭菌剂量应做到最优化选择 ,既能满足对同种骨的有效灭菌 ,又能在降低同种骨免疫原性的同时最大程度保持骨的生物性能 ,确保同种骨移植的安全有效。国际原子能机构 ( IAEA)自 1986年起在发展中国家推广组织移植物辐照灭菌技术 ,中国辐射防护研究院在 IAEA的资助下于 1988年建立组织库 ,后改建为山西省医用组织库 ,向临床提供辐照灭菌同种骨 ,并致力于骨辐照技术在国内的推广。 With prominent features of high penetration,no temperature increases, no harm residues and easy dose control,radiation sterilization technology is widely used in the sterilization of bone allografts. During the radiation sterilization of bone allografts, the irradiation dose should be optimized to ensure sterilization of grafts and preservation of biological properties of bone. The immunogenicity of allografts is decreased by irradiation. IAEA devoted great efforts to generalinzation of the radiation sterilization of tissue allografts in developing countries since 1986. Tissue Bank of China Institute for Radiation Protection (CIRP) was initially established in 1988 with the support of IAEA, afterwards restructured into Shanxi Provincial Tissue Bank (SPTB). The SPTB,as the first manufacturer of the irradiated bone allografts in the country,was granted production license by the State Food and Drug Administration of China.The SPTB sponsored IAEA/RCA Training Courses, National Symposium on Bone Grafting, and National Training Course on Bone Banking. Technique of radiation sterilization for bone grafts has become popularized in China after these activities.
出处 《辐射防护通讯》 2003年第5期16-18,共3页 Radiation Protection Bulletin
关键词 辐照灭菌 骨移植物 中国 骨科疾病 骨免疫原性 Radiation sterilization Bone allografts Bone grafting
  • 相关文献

参考文献5

二级参考文献21

共引文献14

同被引文献29

  • 1刘英飞,仉建国,陈云庆.原位自体骨与同种异体骨混合植骨在脊柱侧弯矫形融合术中的应用[J].中国组织工程研究与临床康复,2007,11(51):10374-10375. 被引量:6
  • 2陈方祥.回收式自体血回输技术及其在手术中的应用[J].中国实用外科杂志,2007,27(2):111-114. 被引量:35
  • 3Steinberg EL, Luger E, Zwas T, et al. Very long-term radiographic and bone scan results of frozen autograft and allograft bone grafting in 17 patients(20 grafts) a 30-to 35-year follow-up. Cell Tissue Bank, 2004, 5(2): 97-104.
  • 4Burkus JK, Sandhu HS, Gornet MF. Influence of rhBMP-2 on the healing patterns associated with allograft interbody constructs in com- parison with autograft. Spine, 2006, 31(7): 775-781.
  • 5Vaccaro AR, Stubbs HA, Block JE. Demineralized bone matrix composite grafting for posterolateral spinal fusion. Orthopedics, 2007, 30(7): 567-570.
  • 6Slosar PJ, Josey R, Reynolds J. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes. Spine J, 2007, 7(3): 301-307.
  • 7Burkus JK, Sandhu HS, Gornet MF, et al. Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic out- comes in anterior lumbar spinal surgery. J Bone Joint Surg (Am), 2005, 87(6): 1205-1212.
  • 8Cheng I, Oshtory R, Wildstein MS. The role of osteobiologics in spinal deformity. Neurosurg Clin N Am, 2007, 18(2): 393-401.
  • 9Rush SM. Bone graft substitutes: osteobiologics. Clin Podiatr Med Surg, 2005, 22(4): 619-630, viii.
  • 10Baba H, Furusawa N, Tanaka Y, et al. Anterior decompression and fusion for cervical myeloradiculopathy secondary to ossification of the posterior ligament. Int Orthop, 1994, 18(4): 204-209.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部